Your browser doesn't support javascript.
loading
[Myopic CNV]. / Myope CNV.
Voykov, B; Ziemssen, F.
Affiliation
  • Voykov B; Department für Augenheilkunde, Eberhard-Karl-Universität Tübingen.
Klin Monbl Augenheilkd ; 228(9): 762-70, 2011 Sep.
Article in De | MEDLINE | ID: mdl-21913145
ABSTRACT
Choroidal neovascularisation secondary to pathological myopia is the most common cause of severe visual impairment in myopic patients younger than 50 years old. The typical features of myopic CNV in contrast to age-related macular degeneration as well as the anatomic characteristics have an impact on the parameters of the baseline and follow-up examinations. As the usually small fibrovascular lesions show a rapid progression in the spontaneous course of the disease and lead to irreversible damage to the photoreceptors, prompt initiation of treatment is mandatory. The superior functional results of anti-VEGF drugs provide the reason for the first-line status of this treatment modality. Increasing safety data and consistent results of prospective pilot trials have proved photodynamic therapy to be inferior. There are signs that PRN-based treatment algorithms may allow for less frequent dosing than in other retinal diseases.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choroidal Neovascularization / Myopia Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Language: De Journal: Klin Monbl Augenheilkd Year: 2011 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choroidal Neovascularization / Myopia Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Language: De Journal: Klin Monbl Augenheilkd Year: 2011 Type: Article